The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02• GutAlive®: Microbiota Collection and Transport in Anaerobic Conditions• From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation•

Microbiome Times

UC San Diego Center for Microbiome Innovation Adds Two Petabytes of Panasas’ HPC Storage for COVID-19 Research
Pharma & Human Health

UC San Diego Center for Microbiome Innovation Adds Two Petabytes of Panasas’ HPC Storage for COVID-19 Research

JUN 30, 2020
IPA response to 2020 AGA Clinical Practice Guidelines on the Role of Probiotics in the Management of Gastrointestinal Disorders
Biotics and Supplements

IPA response to 2020 AGA Clinical Practice Guidelines on the Role of Probiotics in the Management of Gastrointestinal Disorders

JUN 30, 2020
Boost Biomes announces close of Series A and co-development agreement for biostimulants products
Finance

Boost Biomes announces close of Series A and co-development agreement for biostimulants products

JUN 29, 2020
Novozymes acquires PrecisionBiotics Group to advance its business within human health
Biotics and Supplements

Novozymes acquires PrecisionBiotics Group to advance its business within human health

JUN 26, 2020
Enterome Completes €46.3 Million Financing to Progress the Clinical Development of Its Therapeutic Pipeline
Finance

Enterome Completes €46.3 Million Financing to Progress the Clinical Development of Its Therapeutic Pipeline

JUN 25, 2020
Pioneering research reveals certain human genes relate to gut bacteria
Pharma & Human Health

Pioneering research reveals certain human genes relate to gut bacteria

JUN 24, 2020
Live Biotherapeutic Products – a new regulatory approach for the safety assessment of a specific category of biological medicinal products
Pharma & Human Health

Live Biotherapeutic Products – a new regulatory approach for the safety assessment of a specific category of biological medicinal products

JUN 22, 2020
Metabolon, Inc. and DNA Genotek Collaborate on First Ambient-Temperature Microbiome Sampling Solution for Metabolomics
Pharma & Human Health

Metabolon, Inc. and DNA Genotek Collaborate on First Ambient-Temperature Microbiome Sampling Solution for Metabolomics

JUN 18, 2020
New microbiome research of practical value to patients
Gastrointestinal

New microbiome research of practical value to patients

JUN 16, 2020
Stakeholders in microbiome-based therapeutic development convene to address the lack of clarity and standards for OMICS data
Pharma & Human Health

Stakeholders in microbiome-based therapeutic development convene to address the lack of clarity and standards for OMICS data

JUN 15, 2020
Debiopharm’s Microbiome Remodeling Program Licensed to Takeda for the Treatment of Gastrointestinal Disorders
Finance

Debiopharm’s Microbiome Remodeling Program Licensed to Takeda for the Treatment of Gastrointestinal Disorders

JUN 10, 2020